How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.

Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial ...

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.

THE first edition of this admirable and well-known treatise was the single-handed work of Prof. Whittaker, and was published in 1902. Into the second edition, which was published thirteen years later ...

Memory is the faculty by which the brain encodes, stores, and retrieves information. It is a record of experience that guides future action. Memory encompasses the facts and experiential details that ...

Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...

Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. David Kindness is a Certified Public Accountant (CPA) and an expert in the ...

Thomas, Kyle A., Julian De Freitas, Peter DiScioli, and Steven Pinker. "Recursive Mentalizing and Common Knowledge in the Bystander Effect." Journal of Experimental Psychology: General 145, no. 5 ...